Dissertation2018
BI 6727 and gemcitabine combination therapy in pancreatic cancer
- Published
- 1 January 2018
- Citations
- 0
- Type
- Dissertation
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Introduction: Though adjuvant chemotherapy improves survival following surgery, pancreatic cancer carries a poor prognosis. Alternatives are required to the current drug regimens consisting of S-phase dependent drugs such as gemcitabine. … Excerpt only: this text is the publisher’s. Read it in full at the source.